Medtronic 2015 Annual Report Download - page 15

The following are the principal products offered by our Neuromodulation division:
Neurostimulation Systems for Chronic Pain We have a large portfolio of neurostimulation systems, including rechargeable
and non-rechargeable devices and a large selection of leads used to treat chronic back and/or limb pain. Our portfolio of
products includes pain neurostimulation systems with SureScan MRI Technology, including the RestoreSensor (rechargeable)
SureScan MRI, with its proprietary AdaptiveStim technology.
Implantable Drug Infusion Systems Our SynchroMed II Implantable Infusion System delivers small quantities of drug
directly into the intrathecal space surrounding the spinal cord. These devices are used to treat chronic, intractable pain and
severe spasticity associated with cerebral palsy, multiple sclerosis, spinal cord and traumatic brain injuries, and stroke.
Deep Brain Stimulation (DBS) Systems DBS is currently approved in many countries around the world for the treatment of
the disabling symptoms of essential tremor, Parkinson’s disease, refractory epilepsy (outside the U.S.), severe, treatment-
resistant obsessive-compulsive disorder (approved under a Humanitarian Device Exemption (HDE) in the U.S.), and chronic,
intractable primary dystonia (approved under a HDE in the U.S.). Our family of Activa Neurostimulators for DBS includes
Activa SC (single-channel primary cell battery), Activa PC (dual channel primary cell battery), and Activa RC (dual channel
rechargeable battery).
Gastroenterology & Urology (Gastro/Uro) Systems Our Sacral neuromodulation uses InterStim, a neurostimulator, to help
control the symptoms of overactive bladder, (non-obstructive) urinary retention, and chronic fecal incontinence. Currently,
Enterra Therapy is the only gastric electrical stimulation therapy approved in the U.S. (under a HDE), Europe, and Canada for
use in the treatment of intractable nausea and vomiting associated with gastroparesis. The system, which contains a small
neurostimulator and two leads, stimulates the smooth muscles of the lower stomach.
Surgical Technologies
Our Surgical Technologies division develops, manufactures, and markets products and therapies to treat diseases and conditions
of the ear, nose, and throat (ENT) and certain neurological disorders. In addition, the division develops, manufactures, and
markets image-guided surgery and intra-operative imaging systems that facilitate surgical planning during precision cranial,
spinal, sinus, and orthopedic surgeries. Our Advanced Energy business includes products in the emerging field of advanced
energy surgical incision technology, as well as the haemostatic sealing of soft tissue and bone.
The following are the principal products offered by our Surgical Technologies division:
Neurosurgery Our Navigation products are used in cranial, spinal, sinus, and orthopedic surgeries: the StealthStation S7
Navigation and i7 Integrated Navigation Systems, and the O-arm 2D/3D Surgical Imaging System.
ENT The following products treat ENT diseases and conditions: Straightshot M5 Microdebrider Handpiece, the IPC system,
NIM Nerve Monitoring Systems, Fusion ENT Navigation System, as well as surgical products for Snoring and Obstructive
Sleep Apnea.
Advanced Energy Our PEAK Surgery System is a tissue dissection system that consists of the PEAK PlasmaBlade and
PULSAR Generator and is cleared for use in a variety of settings, including plastic reconstructive surgery, general surgery, and
certain conditions of ENT. Our Aquamantys System uses patented transcollation technology to provide haemostatic sealing of
soft tissue and bone and is cleared for use in a variety of surgical procedures, including orthopedic surgery, spine, solid organ
resection and thoracic procedures.
Neurovascular
Our Neurovascular division, which was acquired in the Covidien acquisition, develops, manufactures, and markets products and
therapies to treat diseases of the vasculature in and around the brain. Our products include coils, neurovascular stents, and flow
diversion products, as well as access and delivery products to support procedures.
The following are the principal products offered by our Neurovascular division:
The Pipeline and Pipeline Flex Embolization Devices, endovascular treatments for large or giant wide-necked brain aneurysms;
the Solitaire FR revascularization device for treatment of acute ischemic stroke; and the Apollo Onyx delivery micro catheter,
the first detachable tip micro-catheter available in the U.S.
5